Nanograb

Summer 2023 · Active

AI-generated binders for targeted drug delivery

Location: San Francisco, US

Founded: 2023

Team size: 5

Industries:

About

Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.

Founders

Debesh MandalFounder
Co-founder and CEO of Nanograb. PhD in Computational Biophysics from Imperial College London. Experienced in molecular simulations and building software for scientists. First software hire at Fabricnano
LinkedIn
Christopher LauFounder
Co-founder of Nanograb. M.Eng Biomaterials and Tissue Engineering at Imperial College London. Biomedical engineering experience developing biosensors using aptamers, and a drug delivery device for hypertension management.
LinkedIn Twitter
Shanil PanaraFounder
Cofounder and in silico lead at Nanograb; Imperial College PhD (dropout); Fascinated by all things compute and physics... all in the name of figuring out real life things! Otherwise, I love singing and music in general. Fun fact: I was in an a cappella group for 5 years :)
LinkedIn Twitter